Effects of Omega-3 Fatty Acid Supplementation on Glucose Control and Lipid Levels in Type 2 Diabetes: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Many studies assessed the impact of marine omega-3 fatty acids on glycemic homeostasis and lipid profiles in patients with type 2 diabetes (T2DM), but reported controversial results. Our goal was to systematically evaluate the effects of omega-3 on glucose control and lipid levels. METHODS: Medline, Pubmed, Cochrane Library, Embase, the National Research Register, and SIGLE were searched to identify eligible randomized clinical trials (RCTs). Extracted data from RCTs were analyzed using STATA 11.0 statistical software with fixed or random effects model. Effect sizes were presented as weighted mean differences (WMD) with 95% confidence intervals (95% CI). Heterogeneity was assessed using the Chi-square test with significance level set at p < 0.1. RESULTS: 20 RCT trials were included into this meta-analysis. Among patients with omega-3 supplementation, triglyceride (TG) levels were significantly decreased by 0.24 mmol/L. No marked change in total cholesterol (TC), HbA1c, fasting plasma glucose, postprandial plasma glucose, BMI or body weight was observed. High ratio of EPA/DHA contributed to a greater decreasing tendency in plasma insulin, HbAc1, TC, TG, and BMI measures, although no statistical significance was identified (except TG). FPG levels were increased by 0.42 mmol/L in Asians. No evidence of publication bias was observed in this meta-analysis. CONCLUSIONS: The ratio of EPA/DHA and early intervention with omega 3 fatty acids may affect their effects on glucose control and lipid levels, which may serve as a dietary reference for clinicians or nutritionists who manage diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“meta-analyses of older studies and more recent publications have shown that 4 g/d Downloaded from http://ahajournals.org by on September 1, 2023”
From Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association (2019) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Omega-3 fatty acid supplements have not reduced CVD events or mortality in randomized trials but may have utility in people who require triglyceride reduction (304,306).”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [306]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Evidence does not conclusively support recommending omega-3 (EPA and DHA) supplements for all people with diabetes for the prevention or treatment of cardiovascular events.”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [306]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582 · cited 1×
“We adopted the criterion system developed by Jadad and Schulz [35,36], which had a possible range from 0 to 5 with 2 as a cutoff for the selection of high-quality studies.”
MethodDiagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Dong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817
Prevention and management of type 2 diabetes: dietary components and nutritional strategies
Ley, S. H., Hamdy, O., Mohan, V., & Hu, F. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60613-9 · Cited by 1,301 · cited 1×
“That adherence to a healthy diet can improve glycemic control has been getting more and more attention of clinicians and nutritionists [4,5].”
BackgroundKromann, N., & Green, A. (1980) · PubMed · Cited by 851
The composition of the Eskimo food in north western Greenland.
Bang, H. O., Dyerberg, J., & Sinclair, H. M. (1980) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.12.2657 · Cited by 807 · cited 1×
“attributed such benefits of fish consumption to its main components, omega 3 fatty acids (in particular for eicosapentaenoic acid (C20:5n-3, EPA) and docosahexaenoic acid (C22:6n-3,DHA))—a group of homologue fatty acids belonging to polyunsaturated fatty acids (PUFAs) [7].”
BackgroundYan, Y., Jiang, W., Spinetti, T., Tardivel, A., Castillo, R., Bourquin, C., Guarda, G., Tian, Z., Tschopp, J., & Zhou, R. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.015 · Cited by 784 · cited 1×
“Although no statistical significance but the decreasing trend identified in fasting insulin according to our analysis, animal studies supported the positive effect of omega 3 on the improvement of insulin sensitivity [38,39].”
ResultKromann, N., & Green, A. (1980) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1980.tb01221.x · Cited by 713
González-Périz, A., Horrillo, R., Ferré, N., Gronert, K., Dong, B., Morán-Salvador, E., Titos, E., Martínez-Clemente, M., López-Parra, M., Arroyo, V., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125674 · Cited by 555 · cited 1×
“Although no statistical significance but the decreasing trend identified in fasting insulin according to our analysis, animal studies supported the positive effect of omega 3 on the improvement of insulin sensitivity [38,39].”
ResultKabir, M., Skurnik, G., Naour, N., Pechtner, V., Meugnier, E., Rome, S., Quignard-Boulangé, A., Vidal, H., Slama, G., Clément, K., et al. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.5.1670 · Cited by 316 · cited 7×
“000 US/European [17,20,22,24,25,27,28,30] 8 206 WMD (IV, Fixed) 0.”
BackgroundInfluentialAdverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus
GLAUBER, H., WALLACE, P., GRIVER, K., & BRECHTEL, G. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-663 · Cited by 285 · cited 5×
“000 US/European [17,20,22,24,25,27,28,30] 8 206 WMD (IV, Fixed) 0.”
InfluentialAmerican Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s007 · Cited by 263
Fish oil supplementation in type 2 diabetes: a quantitative systematic review.
Montori, V. M., Farmer, A., Wollan, P. C., & Dinneen, S. F. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1407 · Cited by 242 · cited 2×
“This effect was most remarkable in studies that gave a high dose of omega-3 and with a longer duration, which were in accordance with previous reviews [33,34].”
BackgroundResultFish Consumption, Dietary Long-Chain n-3 Fatty Acids, and Risk of Type 2 Diabetes
Wallin, A., Di Giuseppe, D., Orsini, N., Patel, P. S., Forouhi, N. G., & Wolk, A. (2012) · Diabetes Care · doi:10.2337/dc11-1631 · Cited by 220
McVeigh, G. E., Brennan, G. M., Johnston, G. D., McDermott, B. J., McGrath, L. T., Henry, W. R., Andrews, J. W., & Hayes, J. R. (1993) · Diabetologia · doi:10.1007/bf00399090 · Cited by 193 · cited 3×
“0 g/d DHA) [19,20,24,25,28,30,32] 7 198 WMD (D+L, Random) 0.”
BackgroundPopp‐Snijders, C., Schouten, J. A., Heine, R. J., van der Meer, J., & van der Veen, E. A. (1987) · PubMed · Cited by 187
Rivellese, A. A., Maffettone, A., Iovine, C., Di Marino, L., Annuzzi, G., Mancini, M., & Riccardi, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.11.1207 · Cited by 167 · cited 7×
“8 g/d EPA) [19] 1 16 WMD (IV, Fixed) -2.”
BackgroundInfluentialEffects of Fish Oil Supplementation on Glucose and Lipid Metabolism in NIDDM
Borkman, M., Chisholm, D. J., Furler, S. M., Storlien, L. H., Kraegen, E. W., Simons, L. A., & Chesterman, C. N. (1989) · Diabetes · doi:10.2337/diab.38.10.1314 · Cited by 159
Gubitosi-Klug, R. A., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2148 · Cited by 130
Zheng, J.-S., Huang, T., Yang, J., Fu, Y.-Q., & Li, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044525 · Cited by 126 · cited 7×
“To our surprise, FPG level was slightly elevated in Asians (0.42 mmol/L, 0.058 to 0.781 mmol/L, p = 0.023) but with no significant change in Western population (0.09 mmol/L, -0.154 to 0.330 mmol/L, p = 0.477).”
ResultInfluentialKASIM, S. E., STERN, B., KHILNANI, S., MCLIN, P., BACIOROWSKI, S., & JEN, K.-L. C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-1-1 · Cited by 116 · cited 10×
“000 US/European [17,20,22,24,25,27,28,30] 8 206 WMD (IV, Fixed) 0.”
InfluentialLuo, J., Rizkalla, S. W., Vidal, H., Oppert, J.-M., Colas, C., Boussairi, A., Guerre-Millo, M., Chapuis, A.-S., Chevalier, A., Durand, G., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.5.717 · Cited by 114 · cited 9×
“000 US/European [17,20,22,24,25,27,28,30] 8 206 WMD (IV, Fixed) 0.”
BackgroundInfluentialEffect of Fish Oil Concentrate on Lipoprotein Composition in NIDDM
Schectman, G., Kaul, S., & Kissebah, A. H. (1988) · Diabetes · doi:10.2337/diab.37.11.1567 · Cited by 105
McManus, R. M., Jumpson, J., Finegood, D. T., Clandinin, M. T., & Ryan, E. A. (1996) · Diabetes Care · doi:10.2337/diacare.19.5.463 · Cited by 103 · cited 10×
“855 Duration >8 weeks [13,15,16,20,23] 6 577 WMD (IV, Fixed) -0.”
BackgroundInfluentialWong, C. ‐., Yiu, K. ‐., Li, S. ‐., Lee, S., Tam, S., Lau, C. ‐., & Tse, H. ‐. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02869.x · Cited by 103
Annuzzi, G., Rivellese, A. A., Capaldo, B., Marino, L., Iovine, C., Marotta, G., & Riccardi, G. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90233-s · Cited by 100
Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes
Hartweg, J., Farmer, A. J., Holman, R. R., & Neil, A. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328321b3be · Cited by 100 · cited 2×
“This effect was most remarkable in studies that gave a high dose of omega-3 and with a longer duration, which were in accordance with previous reviews [33,34].”
BackgroundResultEpidemiological Studies in Greenland 1962–1964: I. Diabetes mellitus in Eskimos
Sagild, U., LITTAUER, J., JESPERSEN, C. S., & Andersen, S. (1966) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1966.tb05430.x · Cited by 98
Sirtori, C., Paoletti, R., Mancini, M., Crepaldi, G., Manzato, E., Rivellese, A. A., Pamparana, F., & Stragliotto, E. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.6.1874 · Cited by 93 · cited 5×
“The overall effect of omega-3 intervention remained unchanged for most markers (FFG, PPG, HbA1c, TG, TC, BMI, and BodyWeight) when 1) quality score of included studies were three or more; or 2) included studies were parallel design; or 3) included studies were blinded; or 4) studies with large sample size were exclude…”
BackgroundInfluentialPuhakainen, I., Ahola, I., & Yki‐Järvinen, H. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.1.121 · Cited by 84 · cited 6×
“000 US/European [17,20,22,24,25,27,28,30] 8 206 WMD (IV, Fixed) 0.”
BackgroundInfluentialPooya, S., Jalali, M., Jazayery, A. D., Saedisomeolia, A., Eshraghian, M. R., & Toorang, F. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.04.002 · Cited by 78 · cited 4×
“993 Asian [13,14,16,29] 4 270 WMD (IV, Fixed) 0.”
BackgroundInfluentialPatel, P. S., Forouhi, N. G., Kuijsten, A., Schulze, M. B., van Woudenbergh, G. J., Ardanaz, E., Amiano, P., Arriola, L., Balkau, B., Barricarte, A., et al. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.029314 · Cited by 78
Zhou, Y., Tian, C., & Jia, C. (2012) · British Journal of Nutrition · doi:10.1017/s0007114512002036 · Cited by 78
Okuda, Y., Mizutani, M., Ogawa, M., Sone, H., Asano, M., Asakura, Y., Isaka, M., Suzuki, S., Kawakami, Y., Field, J. B., et al. (1996) · Journal of Diabetes and its Complications · doi:10.1016/1056-8727(95)00081-x · Cited by 66 · cited 9×
“991 Asian [14,16,29] 3 173 WMD (D+L, Random) -0.”
InfluentialLi, D. (2015) · PubMed · doi:10.6133/apjcn.2015.24.1.21 · Cited by 58
ALA, Fatty Fish or Marine n-3 Fatty Acids for Preventing DM?: A Systematic Review and Meta-Analysis
Muley, A., Muley, P., & Shah, M. A. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140515113137 · Cited by 58 · cited 7×
“To our surprise, FPG level was slightly elevated in Asians (0.42 mmol/L, 0.058 to 0.781 mmol/L, p = 0.023) but with no significant change in Western population (0.09 mmol/L, -0.154 to 0.330 mmol/L, p = 0.477).”
ResultInfluentialShidfar, F., Keshavarz, A. A., Hosseyni, S. R., Ameri, A., & Yarahmadi, S. H. (2008) · PubMed · Cited by 56
Molinar-Toribio, E., Pérez-Jiménez, J., Ramos-Romero, S., Romeu, M., Giralt, M., Taltavull, N., Muñoz-Cortes, M., Jáuregui, O., Méndez, L., Medina, I., et al. (2015) · British Journal of Nutrition · doi:10.1017/s0007114514004437 · Cited by 51 · cited 1×
“A more recent study by Molinar-Toribio et al reported that the relatively high ratio of EPA/DHA supplementation significantly decreased inflammation status and resultantly improved the insulin sensitivity in pre-diabetic rats [40], which is accordant with our speculations.”
ResultSchulz, K. F., Chalmers, I., Altman, D. G., Grimes, D. A., & Doré, C. J. (1995) · PubMed · Cited by 49
A Comparison of Fish Oil or Corn Oil Supplements in Hyperlipidemic Subjects with NIDDM
Morgan, W. A., Raskin, P., & Rosenstock, J. (1995) · Diabetes Care · doi:10.2337/diacare.18.1.83 · Cited by 43 · cited 7×
“855 Duration >8 weeks [13,15,16,20,23] 6 577 WMD (IV, Fixed) -0.”
BackgroundInfluentialMetabolic Effects of Omega‐3 Fatty Acids in Type 2 (Non‐Insulin‐Dependent) Diabetic Patients
PELIKÁNOVÁ, T., KOHOUT, M., VÁLEK, J., KAZDOVÁ, L., & BAŠE, J. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35716.x · Cited by 33 · cited 5×
“744 Duration 8 weeks [30] [21] 2 64 WMD (IV, Fixed) 0.”
InfluentialNeil, H. A. W., Ceglarek, U., Thiery, J., Paul, S. K., Farmer, A. A., & Holman, R. R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.09.013 · Cited by 25
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Skulas-Ray, A. C., Wilson, P. W. F., Harris, W. S., Brinton, E. A., Kris-Etherton, P. M., Richter, C. K., Jacobson, T. A., Engler, M. B., Miller, M., Robinson, J. G., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000709 · Cited by 512
Brown, T. J., Brainard, J., Song, F., Wang, X., Abdelhamid, A., & Hooper, L. (2019) · BMJ · doi:10.1136/bmj.l4697 · Cited by 313
The Role of Nutrients in Reducing the Risk for Noncommunicable Diseases during Aging
Bruins, M. J., Van Dael, P., & Eggersdorfer, M. (2019) · Nutrients · doi:10.3390/nu11010085 · Cited by 223
“These findings will be helpful for clinicians and nutritionists who manage patients with diabetes to provide dietary guidance [141].”
BackgroundInfluentialBanaszak, M., Dobrzyńska, M., Kawka, A., Górna, I., Woźniak, D., Przysławski, J., & Drzymała-Czyż, S. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.06.053 · Cited by 161
“…patients showed that omega-3 supplementation, and in particular, a high EPA/DHA ratio (EPA/DHA > 1.5) contributed to a reduction in plasma insulin, glycated haemoglobin (HbA1c), total cholesterol (TC), TG and BMI), however, no statistical signi fi cance was found except for TG ( p < 0.001) [65].”
Influential
Metadata
- Authors
- Chen, C., Yu, X., & Shao, S.
- Affiliations
- Tongji Hospital (CN)
- Corresponding author
- Shao, Shiying
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-10-02
- Volume
- 10
- Issue
- 10
- Pages
- e0139565
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4591987
- OpenAlex
- W1827328405
- Cited by
- 133
- References
- 46
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 13 · 2023: 13 · 2022: 14 · 2021: 15 · 2020: 12 · 2019: 19 · 2018: 11 · 2017: 16 · 2016: 6 · 2015: 2
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (81100581)
- Novo Nordisk
- China International Medical Foundation (20110059)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Keywords
- omega-3 fatty acids, type 2 diabetes, glycemic control, lipid profile, triglycerides, EPA/DHA ratio, HbA1c, fasting blood glucose, postprandial blood glucose, total cholesterol, plasma insulin, body mass index, dietary supplementation
- MeSH terms
- Adolescent, Adult, Blood Glucose, Cholesterol, Diabetes Mellitus, Type 2, Female, Humans, Insulin, Lipids, Male, Middle Aged, Fatty Acids, Omega-3, Randomized Controlled Trials as Topic, Dietary Supplements, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.